Private equity firms circle Australia’s Healthscope

Australian private healthcare provider Healthscope is considering buy-out offers from two more bidders, including more private equity firms, as competition for the company heats up.

  • 31 May 2010

Two new bidders have made offers valuing the company at A$5.80 a share, or A$1.84bn ($1.56bn) in total, Healthscope announced on Monday.

KKR is among the new bidders, potentially in partnership with CVC. The other bidder is understood to be US private healthcare group Tenet Healthcare.

The two bids ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 4,755 19 11.75
2 Citi 4,288 14 10.60
3 Rabobank 2,633 4 6.51
4 Goldman Sachs 2,615 4 6.46
5 Barclays 2,603 8 6.43

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Bank of America Merrill Lynch 57,945.74 181 12.35%
2 Citi 57,243.86 174 12.20%
3 Wells Fargo Securities 48,214.86 152 10.28%
4 JPMorgan 33,301.70 114 7.10%
5 Credit Suisse 25,010.27 80 5.33%